In order to participate in a live webinar or watch an on-demand webinar, you must be registered as a member of this website. If you already have an account, please log in. If not, you can create an account for free.
Register now Login
Esthetics, comfort, and effectiveness are patients' top priorities for patients in periodontal treatment. There is an increasing trend towards minimally invasive procedures. With the help of enamel matrix proteins, periodontal effects can be treated painlessly and effectively. Being present on the market for more than 25 years, Straumann® Emdogain® continues to be the gold standard in periodontal tissue regeneration. The product is proven to regenerate the periodontal tissues lost due to the advancement of periodontitis and is backed up by extensive clinical documentation, including studies with 10-year follow-ups.
We asked long-term experts about their experiences with Emdogain®: What treatment results could be achieved using enamel matrix protein? What needs to be considered when using it? What are indications and contraindications, and what are the limits? How has the product developed over the years, and where are new areas of application opening up? How can this treatment method be optimally and profitably integrated into the practice processes?
The webinar presents clinical cases, a stimulating discussion, and a practical exchange of experience on periodontal regeneration!
The dental professionals addressed are Dental assistants, Dental hygienists, General practitioners, Implantologists, Surgeons, and Periodontists of all levels.
Language: Recorded in German with English subtitles.
Learning objectives:
* The Straumann Group's products and solutions displayed might not be available or cleared in your country. Please consult your local organization for more information.
** The webinar is being recorded. In case you are experiencing issues with the live webinar, due to high traffic, you will be able to enjoy the recorded lecture the following day.
1CE
1CE
1CE
1CE
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Tribune Group designates this activity for 1 continuing education credits.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH.
Los Angeles, USA
Tue., Jan. 3, 18:00
Mexico City, Mexico
Tue., Jan. 3, 20:00
New York, USA
Tue., Jan. 3, 21:00
London, UK
Wed., Jan. 4, 02:00
Berlin, Germany
Wed., Jan. 4, 03:00
Bucharest, Romania
Wed., Jan. 4, 04:00
Moscow, Russia
Wed., Jan. 4, 05:00
Abu Dhabi, UAE
Wed., Jan. 4, 06:00
New Delhi, India
Wed., Jan. 4, 07:30
Bangkok, Thailand
Wed., Jan. 4, 09:00
Beijing, China
Wed., Jan. 4, 10:00
Singapore
Wed., Jan. 4, 10:00
Tokyo, Japan
Wed., Jan. 4, 11:00
Sydney, Australia
Wed., Jan. 4, 13:00
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH.
English
German
French
Italian
Spanish
